Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 1, 2013, Pages 48-53

  Mohammadzadeh, L ^a   Samedanifard, S H ^a   Keshavarzi, A ^a   Alimoghaddam, K ^a   Larijani, B ^a   Ghavamzadeh, A ^a   Ahmadi, A S ^a   Shojaeifard, A ^a   Ostadali, M R ^b   Sharifi, A M ^a   Amini, M R ^b   Mahmoudian, A ^c   Fakhraei, H ^b   Aalaa, M ^b   Mohajeri Tehrani, M R ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

critical limb ischemia; peripheral arterial disease; stem cell transplantation

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DIABETIC PATIENT; ERYTHEMA; HUMAN; LEG AMPUTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; PAIN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL MOBILIZATION; WOUND HEALING;

AGED; ANKLE BRACHIAL INDEX; DIABETIC ANGIOPATHIES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PAIN MANAGEMENT; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84872342543     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1311646     Document Type: Article

References (28)

1. Barcelos L. S., Duplaa C., Kränkel N. et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res: 2009; 104 1095 1102
2. Battiwalla M., Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy: 2009; 11 503 515
3. Burt R. K., Testori A., Oyama Y. et al. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant: 2010; 45 111 116
4. Cho H. J., Kim H. S., Lee M. M. et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation: 2003; 108 2918 2925
5. de Win M. M., Theuvenet W. J., Roche P. W. et al. The paper grip test for screening on intrinsic muscle paralysis in the foot of leprosy patients. Int J Lepr Other Mycobact Dis: 2002; 70 16 24 (Pubitemid 34761189)
6. Duh E., Aiello L. P. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes: 1999; 48 1899 1906 (Pubitemid 29458350)
7. Fadini G. P., Avogaro A. Autologous transplantation of granulocyte colony-stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care: 2006; 29 478 479 author reply 479-480 (Pubitemid 44106562)
8. Hicks M. L., Lonial S., Langston A. et al. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion: 2007; 47 629 635 (Pubitemid 46449623)
9. Huang P., Li S., Han M. et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care: 2005; 28 2155 2160 (Pubitemid 41242461)
10. Iba O., Matsubara H., Nozawa Y. et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation: 2002; 106 2019 2025 (Pubitemid 35176311)
11. Ishida A., Ohya Y., Sakuda H. et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J: 2005; 69 1260 1265 (Pubitemid 41382950)
12. Ishikawa M., Asahara T. Endothelial progenitor cell culture for vascular regeneration. Stem Cells Dev: 2004; 13 344 349 (Pubitemid 39223284)
13. Jackson K. A., Majka S. M., Wang H. et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest: 2001; 107 1395 1402 (Pubitemid 32522033)
14. Kajiguchi M., Kondo T., Izawa H. et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J: 2007; 71 196 201 (Pubitemid 46182692)
15. Kienstra K. A., Jackson K. A., Hirschi KK. Injury mechanism dictates contribution of bone marrow-derived cells to murine hepatic vascular regeneration. Pediatr Res: 2008; 63 131 136
16. Kwon D. S., Gao X., Liu Y. B. et al. Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J: 2008; 5 453 463 (Pubitemid 351874520)
17. Lechner A., Habener J. F. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab: 2003; 284 E259 E266 (Pubitemid 36120097)
18. Loomans C. J., de Koning E. J., Staal F. J. et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes: 2004; 53 195 199 (Pubitemid 38044715)
19. Minamino K., Adachi Y., Okigaki M. et al. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells: 2005; 23 347 354 (Pubitemid 40404453)
20. Ono K., Tsuchida A., Kawai H. et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol: 2003; 14 1591 1598 (Pubitemid 36687061)
21. Dorros G., Jaff M. R., Dorros A. M. et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation: 2001; 104 2057 2062 (Pubitemid 33027046)
22. Oyibo S. O., Jude E. B., Tarawneh I. et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care: 2001; 24 84 88 (Pubitemid 32104225)
23. Seiler C., Pohl T., Wustmann K. et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation: 2001; 104 2012 2017 (Pubitemid 33027039)
24. Tateishi-Yuyama E., Matsubara H., Murohara T. et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet: 2002; 360 427 435
25. Tepper O. M., Galiano R. D., Capla J. M. et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation: 2002; 106 2781 2786 (Pubitemid 35396976)
26. Wang Y., Tägil K., Ripa R. S. et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol: 2005; 100 477 483
27. Yang X. F., Wu Y. X., Wang H. M. et al. Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder. Zhonghua Nei Ke Za Zhi: 2005; 44 95 98
28. Zafarghandi M. R., Ravari H., Aghdami N. et al. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia. Cytotherapy: 2010; 12 783 791